Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.
Pivotal Therapeutics Inc. (PVO)
SEDAR Information
Information d'entreprise
Capitalisation
Bulletins
2017-1012 - Retrait - Pivotal Therapeutics Inc. (PVO)
Le 23 octobre 2017
Les actions ordinaires de Pivotal Therapeutics Inc. seront radiées au marché fermer aujourd'hui, le 23 octobre 2017.
Les actions de Pivotal Therapeutics Inc. sont actuellement arrêtées.
Date : Clôture du marché, le 23 octobre 2017
Symbole : PVO
